Definitive Healthcare (NASDAQ:DH) Sees Large Volume Increase

Shares of Definitive Healthcare Corp. (NASDAQ:DH) saw an uptick in trading volume on Monday . 632,035 shares changed hands during trading, an increase of 10% from the previous session’s volume of 575,555 shares.The stock last traded at $7.15 and had previously closed at $7.06.

Analyst Upgrades and Downgrades

DH has been the subject of a number of recent analyst reports. Needham & Company LLC downgraded Definitive Healthcare from a “buy” rating to a “hold” rating in a report on Wednesday, January 17th. Barclays boosted their price target on Definitive Healthcare from $10.00 to $11.00 and gave the company an “equal weight” rating in a research note on Friday, March 1st. Stifel Nicolaus cut their target price on shares of Definitive Healthcare from $12.00 to $11.00 and set a “buy” rating on the stock in a research note on Wednesday, January 17th. Canaccord Genuity Group increased their price objective on shares of Definitive Healthcare from $9.00 to $10.00 and gave the stock a “hold” rating in a research report on Thursday, February 29th. Finally, Canaccord Genuity Group lowered Definitive Healthcare from a “buy” rating to a “hold” rating in a research report on Friday, January 5th. Seven analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, Definitive Healthcare currently has a consensus rating of “Hold” and an average price target of $11.31.

Definitive Healthcare Stock Performance

The business has a 50 day simple moving average of $8.28 and a two-hundred day simple moving average of $8.31. The company has a quick ratio of 2.31, a current ratio of 2.31 and a debt-to-equity ratio of 0.20.

Definitive Healthcare (NASDAQ:DH) last posted its quarterly earnings data on Wednesday, February 28th. The company reported ($0.01) earnings per share for the quarter, missing the consensus estimate of $0.01 by ($0.02). Definitive Healthcare had a positive return on equity of 0.43% and a negative net margin of 80.40%. The company had revenue of $65.93 million during the quarter, compared to the consensus estimate of $66.01 million. Research analysts forecast that Definitive Healthcare Corp. will post 0.11 EPS for the current fiscal year.

Institutional Investors Weigh In On Definitive Healthcare

Large investors have recently added to or reduced their stakes in the company. Conestoga Capital Advisors LLC lifted its holdings in shares of Definitive Healthcare by 12.1% in the 4th quarter. Conestoga Capital Advisors LLC now owns 5,521,137 shares of the company’s stock worth $54,880,000 after acquiring an additional 595,280 shares during the last quarter. Vanguard Group Inc. boosted its position in Definitive Healthcare by 6.2% during the third quarter. Vanguard Group Inc. now owns 4,331,543 shares of the company’s stock valued at $34,609,000 after buying an additional 254,726 shares during the period. Brown Advisory Inc. grew its stake in shares of Definitive Healthcare by 0.7% during the third quarter. Brown Advisory Inc. now owns 3,967,991 shares of the company’s stock valued at $31,704,000 after buying an additional 26,276 shares during the last quarter. Massachusetts Financial Services Co. MA increased its holdings in shares of Definitive Healthcare by 76.0% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 3,466,514 shares of the company’s stock worth $34,457,000 after buying an additional 1,496,652 shares during the period. Finally, Bank of New York Mellon Corp lifted its stake in shares of Definitive Healthcare by 11.7% in the 3rd quarter. Bank of New York Mellon Corp now owns 1,090,136 shares of the company’s stock valued at $8,710,000 after acquiring an additional 113,963 shares during the last quarter. Hedge funds and other institutional investors own 98.67% of the company’s stock.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.